<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8250">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01931904</url>
  </required_header>
  <id_info>
    <org_study_id>IRB000009745</org_study_id>
    <secondary_id>1R01EY023285</secondary_id>
    <nct_id>NCT01931904</nct_id>
  </id_info>
  <brief_title>Eye Pressure Lowering Surgery</brief_title>
  <acronym>IOP</acronym>
  <official_title>OBSERVATIONAL STUDY OF OCULAR BLOOD FLOW PRE- AND POST- TRABECULECTOMY SURGERY USING FUNCTIONAL AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <authority>United States: National Institutes of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if lowering the pressure inside the eye improves
      blood flow to the eye.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using high-speed ocular coherence tomography (OCT) systems, we have developed new methods to
      image and measure optic nerve head (ONH) and retinal blood flow. Preliminary results have
      shown that visual field (VF) loss is more highly correlated with retinal blood flow as
      measured by OCT than any neural structure measured by OCT or other imaging modality.
      Accordingly, the goal of the proposed project is to improve the diagnostic and prognostic
      evaluation of glaucoma by further developing novel functional OCT measurements using
      ultrahigh-speed (70-100 kHz) OCT technology.

      Retinal blood flow, ONH circulation, optic disc rim volume, peripapillary nerve fiber layer
      volume, and macular ganglion cell complex volume are all pieces of the same glaucoma puzzle.
      This project will develop novel imaging methods that allow us to look at the whole picture
      using one tool - ultrahigh-speed OCT.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Effects of Intraocular Pressure (IOP) Reduction on Ocular Perfusion</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To determine if IOP reduction improves ocular perfusion.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Trabeculectomy Patients</arm_group_label>
    <description>20 glaucoma patients undergoing trabeculectomy surgery to lower IOP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>20 patients undergoing cataract surgery will be selected as a control group</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This study will measure blood flow changes in 20 glaucoma patients undergoing
        trabeculectomy surgery to lower IOP. Another 20 patients undergoing cataract surgery will
        be selected as a control group.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects diagnosed with perimetric open angle glaucoma or chronic angle closure
             glaucoma.

          -  Subjects scheduled to undergo trabeculectomy surgery

        Exclusion Criteria:

          -  Best-corrected visual acuity less than 20/40

          -  Age &lt; 40 or &gt;80 years

          -  Refractive error of &gt; +3.00 D or &lt; -7.00 D

          -  Previous vision correction surgery such as Laser-Assisted in situ    Keratomileusis
             (LASIK) or Photorefractive Keratectomy (PRK)

          -  Previous intraocular surgery except for uncomplicated cataract extraction   with
             posterior chamber intraocular lens implantation

          -  Diabetic retinopathy

          -  History of heart failure, myocardial infarction, transient ischemic attack or stroke

          -  Other diseases that may cause VF loss or optic disc abnormalities

          -  Inability to clinically view or photograph the optic discs due to media opacity or
             poorly dilating pupil

          -  Inability to perform reliably on automated VF testing

          -  Life-threatening or debilitating illness making it unlikely patient will successfully
             complete the study.

          -  Refusal of informed consent or of commitment to the full length of the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Morrison, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oregon Health and Science University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Janice Ladwig</last_name>
    <phone>503-494-8024</phone>
    <email>ladwig@ohsu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Denny Romfh</last_name>
    <phone>503-494-4351</phone>
    <email>romfhd@ohsu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>OHSU</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Ladwig</last_name>
      <phone>503-494-8024</phone>
      <email>ladwig@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Denny Romfh</last_name>
      <phone>503-494-4351</phone>
      <email>romfhd@ohsu.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Beth Edmunds, MD, Ph. D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mansi Parikh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hana Takusagawa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rebecca Armour, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lorinna Lombardi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Huang, MD, Ph. D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shandiz Tehrani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://coollab.net</url>
  </link>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 7, 2014</lastchanged_date>
  <firstreceived_date>August 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>David Huang</investigator_full_name>
    <investigator_title>John Morrison, M. D., Kenneth Swan Professor of Ophthalmology, Glaucoma Services Director</investigator_title>
  </responsible_party>
  <keyword>IOP</keyword>
  <keyword>Glaucoma</keyword>
  <keyword>Trabeculectomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
